Increased levels of IL-6 are linked to neurodegenerative diseases (Shan et al., 2024), and research studies reveal that PD patients’ blood and CSF have higher levels of IL-6 (Liu et al., 2022). The gene discussed is IL6; the disease is Parkinson disease.